Fonts Size

Change Color


Healthcare facilities are required to complete the Training Programme on Abu Dhabi Healthcare Guidelines for Health Media & Advertising System as mentioned in circular number 26/2023, for more information Click Here

DOH urges all healthcare and pharmaceutical facilities & Health professional to Adhere to the circular number(63\2021) by updating the details of the mobile number & e-mail address in order to receive all circulars & letters issued by DOH, for more information Click Here

Future of Healthcare Series Arab Health 2022

The UAE was one of the first countries to participate in clinical trials of COVID-19 vaccines, which contributed to accelerating the pace of vaccine development and distribution to the world as part of the continuous efforts to combat the pandemic. The emirate participated in phase III clinical trials of Sinopharm and the supplementary study of the immune response to Sinopharm for children aged 3 to 17, in addition to phase III for clinical trials of the Russian human adenovirus-based Covid-19 vaccine, among others.
With regards to research, Abu Dhabi doubled its research capabilities during 2021 to develop scientific and clinical research, the number of which exceeded the research projects that were conducted during the five years preceding 2021. In this context, DoH launched the “Research Registry for COVID-19”, which is a unified platform to support R&D efforts in the fight against COVID-19, facilitating scientific discoveries to tackle the virus. To date, the registry has received 376 scientific papers, 325 of which were approved and 46 were published. Moreover, 67 facilities licensed for healthcare research were established across the emirate.


Research and Innovation in Life Science

January 25, 2022 - 14:00 – 14:45

  • The impact of covid-19 on life science, research and clinical trials
  • What do countries like the UAE need to do to contribute to Research and Innovation global efforts

Watch the panel discussion live stream on YouTube

The live stream will be available during the announced time and later.

Panelists / Moderator

Hossam Nazmy - Panelist Director, Policy and Public affairs, Pfizer
Ahmed Magdi - Panelist Head of Corporate Communications - UAE, Roche Pharmaceuticals Middle East FZCO
Dr. Asma Al Mannaei - Panelist Executive Director of the Research and Innovation Centre at the Department of Health - Abu Dhabi
Ghaleb Al Ahdab - Panelist Government Affairs Associate Director - Gulf AstraZeneca.
Jeffrey P. Kemprecos Director Communications, Government Affairs & Market Access GSK-Gulf
Nick Webster - Moderator The National

Future of Healthcare Series

Global Collaboration in Fighting the Pandemics

Find out more

The Future of Digital Health in healthcare delivery

Find out more

The Future Human Capital in Healthcare

Find out more

Future Healthcare Systems Post Covid-19

Find out more

Research and Innovation in Life Science

Find out more

Subscribe for updates

Thanks for Subscribing

Last updated: 16 Jun 2024

Mobile For an optimal experience please
rotate your device to portrait mode